Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.51−0.13 (-0.42%)
Close on Nov 18, 2026Market cap $2.12BP/E –Yield –
Alamar Biosciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$15.14M | – |
| Q2 FY2026 | Jun 30, 2026 | -$13.53M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.35M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.89M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.92M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.55M | – |
See a number that looks wrong?